Israel Discount Bank of New York Cuts Position in Bath & Body Works, Inc. (NYSE:BBWI)

Israel Discount Bank of New York cut its position in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 2.8% in the fourth quarter, HoldingsChannel reports. The firm owned 10,812 shares of the company’s stock after selling 317 shares during the period. Israel Discount Bank of New York’s holdings in Bath & Body Works were worth $467,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of BBWI. Denali Advisors LLC acquired a new position in Bath & Body Works during the 4th quarter worth approximately $27,000. GAMMA Investing LLC purchased a new position in Bath & Body Works in the 4th quarter valued at about $27,000. Front Row Advisors LLC bought a new position in shares of Bath & Body Works during the third quarter worth about $25,000. Trust Co. of Vermont acquired a new stake in shares of Bath & Body Works in the third quarter valued at approximately $27,000. Finally, Turtle Creek Wealth Advisors LLC acquired a new position in shares of Bath & Body Works during the fourth quarter valued at approximately $35,000. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Bath & Body Works news, insider Thomas E. Mazurek sold 4,285 shares of the firm’s stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the transaction, the insider now owns 45,992 shares of the company’s stock, valued at $2,248,548.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $53.00 price objective on shares of Bath & Body Works in a research note on Friday, April 5th. Barclays lowered shares of Bath & Body Works from an “overweight” rating to an “equal weight” rating and lifted their target price for the company from $37.00 to $45.00 in a research report on Thursday, January 4th. TD Cowen boosted their target price on shares of Bath & Body Works from $35.00 to $55.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st. Wells Fargo & Company boosted their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock an “equal weight” rating in a research note on Wednesday, April 24th. Finally, BMO Capital Markets lifted their target price on shares of Bath & Body Works from $48.00 to $50.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating to the company. According to MarketBeat, Bath & Body Works presently has a consensus rating of “Hold” and an average target price of $46.73.

Get Our Latest Stock Report on Bath & Body Works

Bath & Body Works Trading Up 1.0 %

BBWI stock traded up $0.45 during trading on Monday, reaching $46.49. The stock had a trading volume of 1,620,907 shares, compared to its average volume of 2,705,196. The stock’s 50 day moving average is $46.22 and its two-hundred day moving average is $40.67. Bath & Body Works, Inc. has a 52 week low of $27.30 and a 52 week high of $50.34. The firm has a market cap of $10.46 billion, a PE ratio of 11.96, a PEG ratio of 1.49 and a beta of 1.86.

Bath & Body Works (NYSE:BBWIGet Free Report) last released its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.21. The business had revenue of $2.91 billion during the quarter, compared to analyst estimates of $2.84 billion. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The company’s revenue for the quarter was up .8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.86 earnings per share. On average, research analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Shareholders of record on Friday, February 23rd were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 1.72%. The ex-dividend date was Thursday, February 22nd. Bath & Body Works’s payout ratio is 20.78%.

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Read More

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.